TRIB
Trinity Biotech
TRIB
TRIB
29 hedge funds and large institutions have $12.9M invested in Trinity Biotech in 2019 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 4 increasing their positions, 10 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
67% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 9
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $29K
Holders
29
Holding in Top 10
–
Calls
–
Puts
$29K
Top Buyers
| 1 | +$668K | |
| 2 | +$411K | |
| 3 | +$66.2K | |
| 4 |
CCM
Covington Capital Management
Los Angeles,
California
|
+$4K |
| 5 |
Wells Fargo
San Francisco,
California
|
+$1K |
Top Sellers
| 1 | -$1.08M | |
| 2 | -$735K | |
| 3 | -$581K | |
| 4 |
HA
Heartland Advisors
Milwaukee,
Wisconsin
|
-$387K |
| 5 |
ARM
Adirondack Research & Management
Guilderland,
New York
|
-$132K |